News

Inpatients rated the overall experience of care at Royal Brompton & Harefield NHS Foundation Trust as 8.8 out of 10, according to results from the Care Quality Commission (CQC) national adult inpatient survey.

A major lung cancer screening trial has found that patients with a high risk of developing lung cancer have a 73 per cent chance of living for five years or more if the disease is identified at an early stage.

​​​​​​​Professor Dudley Pennell, director of the National Institute for Health Research (NIHR) cardiovascular biomedical research unit (BRU) and the Trust’s cardiovascular magnetic resonance unit (CMR), has been given an NIHR senior investigator award for a four-year term. 

A pioneering treatment for patients with chronic bronchitis has been carried out for the first time in the UK as part of a trial led by experts at Royal Brompton Hospital and Chelsea and Westminster Hospital in London.